Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
6,446,149
-
Share change
-
-189,067
-
Total reported value
-
$73,420,000
-
Price per share
-
$11.39
-
Number of holders
-
11
-
Value change
-
-$1,907,297
-
Number of buys
-
3
-
Number of sells
-
8
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q3 2019
As of 30 Sep 2019,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,446,149 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Atlas Venture Advisors, Inc., Aquilo Capital Management, LLC, VICTORY CAPITAL MANAGEMENT INC, BlueCrest Capital Management Ltd, Laurion Capital Management LP, Pentwater Capital Management LP, MILLENNIUM MANAGEMENT LLC, and NORGES BANK.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.